MR
GeneDx Holdings Pipeline
| Drug | Indication | Phase |
|---|---|---|
| GenomeDx™/ExomeDx™ | Rare Genetic Diseases (First-line) | Commercial |
| Rapid/ultraRapid WGS | Neonatal/Pediatric Critical Care | Commercial |
| Prenatal Genetic Testing | Prenatal Genetic Anomalies | Commercial |
| GeneDx Infinity™ Biopharma | Drug Discovery & Clinical Trial Enrichment | Commercial/Development |
| Newborn Screening Initiative | Population Genomic Screening | Pilot/Development |
Leadership Team at GeneDx Holdings
KS
Katherine Stueland
Chief Executive Officer
KF
Kevin Feeley
Chief Financial Officer
LG
Linda Genen
Chief Medical Officer
BD
Bryan Dechairo
Chief Operating Officer
HC
Heidi Chen
Chief Legal Officer
LG
Lisa Gurry
Chief Business Officer
MD
Melanie Duquette
Chief Growth Officer
JB
Jami Biliboaca
Chief People Officer